# Filing Detail

Form DRS - Draft Registration Statement:
SEC Accession No. 0000950123-16-017103
Filing Date
2016-05-13
Accepted
2016-05-13 13:46:27
Documents
11

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | filename1.htm | DRS | 2439122
2 | GRAPHIC | g183927g13v16.jpg | GRAPHIC | 74854
3 | GRAPHIC | g183927g17n95.jpg | GRAPHIC | 51876
4 | GRAPHIC | g183927g18j83.jpg | GRAPHIC | 99604
5 | GRAPHIC | g183927g18l30.jpg | GRAPHIC | 67103
6 | GRAPHIC | g183927g21w10.jpg | GRAPHIC | 33374
7 | GRAPHIC | g183927g22l44.jpg | GRAPHIC | 121668
8 | GRAPHIC | g183927g33r07.jpg | GRAPHIC | 61125
9 | GRAPHIC | g183927g84b16.jpg | GRAPHIC | 34581
10 | GRAPHIC | g183927g84i85.jpg | GRAPHIC | 51063
11 | GRAPHIC | g183927g90k59.jpg | GRAPHIC | 44917
| Complete submission text file | 0000950123-16-017103.txt |  | 3317573

Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

EIN.: 473173478
Type: DRS | Act: 33 | File No.: 377-01325 | Film No.: 161647437
SIC: 2836 Biological Products, (No Diagnostic Substances)